骨量减少                        
                
                                
                        
                            PTEN公司                        
                
                                
                        
                            癌症研究                        
                
                                
                        
                            医学                        
                
                                
                        
                            酒                        
                
                                
                        
                            骨质疏松症                        
                
                                
                        
                            内科学                        
                
                                
                        
                            化学                        
                
                                
                        
                            信号转导                        
                
                                
                        
                            生物化学                        
                
                                
                        
                            骨矿物                        
                
                                
                        
                            PI3K/AKT/mTOR通路                        
                
                        
                    
            作者
            
                Yixuan Chen,Hongping Yu,Daoyu Zhu,Pei Liu,Junhui Yin,Delin Liu,Minghao Zheng,Junjie Gao,Changqing Zhang,Youshui Gao            
         
                    
        
    
            
            标识
            
                                    DOI:10.1096/fj.201902463rr
                                    
                                
                                 
         
        
                
            摘要
            
            Alcohol consumption is regarded as one of the leading risk factors for secondary osteopenia. Coupled angiogenesis and osteogenesis via distinct type-H vessels orchestrates subtle biological processes of bone homeostasis. The dysfunction of angiogenesis and osteogenesis contributes to decreased bone mass during the development of osteopenia. Herein, we identified microRNA-136-3p was remarkedly downregulated in the mouse model of alcohol-induced osteopenia. Following the alcohol administration, downregulated microRNA-136-3p significantly suppressed vascularization and osteogenic differentiation in human umbilical vein endothelial cells (HUVECs) and bone mesenchymal stem cells (BMSCs), respectively. Furthermore, microRNA-136-3p could target phosphatase and tensin homolog deleted on chromosome ten (PTEN) in both HUVECs and BMSCs, thus substantially modulating the capacity of vessel formation and osteogenic differentiation. In the mouse model, microRNA-136-3p Agomir ameliorated alcohol-induced osteopenia, with the concomitant restoration of bone mass and type-H vessel formation. For the first time, this study demonstrated the pivotal role of microRNA-136-3p/PTEN axis in regulations of vascularization and bone formation, which might become the potential therapeutic target of alcohol-induced bone loss.
         
            
 
                 
                
                    
                    科研通智能强力驱动
Strongly Powered by AbleSci AI